LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.00043333
27.49 27.76 2213 1723 1.2843 1.0858
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
27.49 27.76 2249 1723 1.3052 1.0915
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
27.49 27.76 2290 1723 1.3290 1.0978
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
29.19 27.76 53 1863 0.0284 0.1125
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
29.19 27.76 2409 1863 1.2930 1.0865
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
29.19 27.76 2391 1863 1.2833 1.0839
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
29.19 27.76 2452 1863 1.3161 1.0926
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
30.90 27.76 74 2032 0.0364 0.1715
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
30.90 27.76 2652 2032 1.3049 1.0878
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
30.90 27.76 2626 2032 1.2921 1.0845
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
30.90 27.76 2664 2032 1.3108 1.0893
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
32.60 27.76 71 2235 0.0318 0.1599
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
32.60 27.76 2884 2235 1.2899 1.0820
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
32.60 27.76 2839 2235 1.2698 1.0769
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
32.60 27.76 2877 2235 1.2868 1.0812
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
34.30 27.76 113 2449 0.0461 0.2426
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
34.30 27.76 3177 2449 1.2968 1.0821
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
34.30 27.76 3038 2449 1.2401 1.0677
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
34.30 27.76 3092 2449 1.2622 1.0734
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
36.01 27.76 153 2662 0.0575 0.2960
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
36.01 27.76 3477 2662 1.3057 1.0827
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
36.01 27.76 3365 2662 1.2636 1.0724
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
36.01 27.76 3405 2662 1.2787 1.0761
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
37.71 27.76 160 2877 0.0556 0.2990
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
37.71 27.76 3686 2877 1.2809 1.0753
MN20160318_Q01
I14